Author: ImageneBio, Inc.

Posted Date:

April 13, 2026

ImageneBio Announces $30 Million Private Placement

ImageneBio, Inc.

April 13, 2026
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ImageneBio, Inc.

March 17, 2026
ImageneBio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update

ImageneBio, Inc.

March 10, 2026
ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer

ImageneBio, Inc.

February 10, 2026